Rank | Gene Set | Z-score |
---|---|---|
1 | surfactant homeostasis (GO:0043129) | 7.91071617 |
2 | chemical homeostasis within a tissue (GO:0048875) | 6.17730708 |
3 | positive regulation of vasculogenesis (GO:2001214) | 5.82224780 |
4 | regulation of vasculogenesis (GO:2001212) | 5.76007098 |
5 | lymph vessel development (GO:0001945) | 5.73457624 |
6 | vascular endothelial growth factor signaling pathway (GO:0038084) | 5.70323170 |
7 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 4.99289981 |
8 | * regulation of endothelial cell differentiation (GO:0045601) | 4.86487337 |
9 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 4.77817280 |
10 | endothelium development (GO:0003158) | 4.51477000 |
11 | * negative regulation of blood vessel endothelial cell migration (GO:0043537) | 4.43829592 |
12 | angiogenesis involved in wound healing (GO:0060055) | 4.14299027 |
13 | basement membrane organization (GO:0071711) | 4.09628714 |
14 | endothelial cell morphogenesis (GO:0001886) | 4.01880281 |
15 | renal filtration (GO:0097205) | 3.90365571 |
16 | glomerular filtration (GO:0003094) | 3.73826557 |
17 | cellular response to nitric oxide (GO:0071732) | 3.70586836 |
18 | venous blood vessel morphogenesis (GO:0048845) | 3.63960344 |
19 | * positive regulation of endothelial cell differentiation (GO:0045603) | 3.62462241 |
20 | lung lobe morphogenesis (GO:0060463) | 3.51439650 |
21 | * negative regulation of endothelial cell migration (GO:0010596) | 3.51311810 |
22 | lung vasculature development (GO:0060426) | 3.48289200 |
23 | * blood vessel maturation (GO:0001955) | 3.43362303 |
24 | cell migration involved in sprouting angiogenesis (GO:0002042) | 3.42998696 |
25 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 3.41066690 |
26 | positive regulation of p38MAPK cascade (GO:1900745) | 3.41013651 |
27 | Notch signaling involved in heart development (GO:0061314) | 3.39932738 |
28 | * morphogenesis of an endothelium (GO:0003159) | 3.39582092 |
29 | * endothelial tube morphogenesis (GO:0061154) | 3.39582092 |
30 | patterning of blood vessels (GO:0001569) | 3.38148638 |
31 | positive regulation of receptor recycling (GO:0001921) | 3.37883214 |
32 | apoptotic cell clearance (GO:0043277) | 3.36519447 |
33 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 3.34802647 |
34 | axon extension involved in axon guidance (GO:0048846) | 3.34802647 |
35 | cell migration involved in heart development (GO:0060973) | 3.33792647 |
36 | endocrine process (GO:0050886) | 3.31922805 |
37 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 3.31922805 |
38 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 3.31922805 |
39 | vasculogenesis (GO:0001570) | 3.26907281 |
40 | * endothelial cell differentiation (GO:0045446) | 3.26377669 |
41 | cell adhesion mediated by integrin (GO:0033627) | 3.26046886 |
42 | endothelial cell chemotaxis (GO:0035767) | 3.25767601 |
43 | substrate-dependent cell migration (GO:0006929) | 3.22981538 |
44 | blood vessel endothelial cell migration (GO:0043534) | 3.21274304 |
45 | hyaluronan catabolic process (GO:0030214) | 3.20145910 |
46 | low-density lipoprotein particle clearance (GO:0034383) | 3.16790934 |
47 | regulation of p38MAPK cascade (GO:1900744) | 3.15675373 |
48 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.13531311 |
49 | * lymphangiogenesis (GO:0001946) | 3.12620544 |
50 | respiratory tube development (GO:0030323) | 3.11947504 |
51 | * regulation of blood vessel endothelial cell migration (GO:0043535) | 3.11651155 |
52 | establishment of endothelial barrier (GO:0061028) | 3.09733069 |
53 | * blood vessel remodeling (GO:0001974) | 3.08686910 |
54 | stress fiber assembly (GO:0043149) | 3.08510378 |
55 | protein localization to endosome (GO:0036010) | 3.06040453 |
56 | positive regulation of urine volume (GO:0035810) | 3.04181083 |
57 | * wound healing, spreading of epidermal cells (GO:0035313) | 3.03904042 |
58 | cAMP biosynthetic process (GO:0006171) | 3.02412535 |
59 | positive regulation of macrophage cytokine production (GO:0060907) | 3.02099547 |
60 | cellular response to reactive nitrogen species (GO:1902170) | 3.01560415 |
61 | negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394) | 3.01253219 |
62 | neuron remodeling (GO:0016322) | 3.00487904 |
63 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 3.00415310 |
64 | adhesion of symbiont to host (GO:0044406) | 2.96609592 |
65 | endodermal cell differentiation (GO:0035987) | 2.95266070 |
66 | sprouting angiogenesis (GO:0002040) | 2.94241133 |
67 | * angiogenesis (GO:0001525) | 2.94190215 |
68 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.93466030 |
69 | mesodermal cell differentiation (GO:0048333) | 2.91423462 |
70 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.88619349 |
71 | adhesion of symbiont to host cell (GO:0044650) | 2.88377529 |
72 | virion attachment to host cell (GO:0019062) | 2.88377529 |
73 | negative regulation of angiogenesis (GO:0016525) | 2.88338641 |
74 | positive regulation of endothelial cell migration (GO:0010595) | 2.88231142 |
75 | negative regulation of vascular permeability (GO:0043116) | 2.87889103 |
76 | * regulation of endothelial cell migration (GO:0010594) | 2.87091122 |
77 | response to nitric oxide (GO:0071731) | 2.86145000 |
78 | response to xenobiotic stimulus (GO:0009410) | 2.85501823 |
79 | renal system process involved in regulation of blood volume (GO:0001977) | 2.83150763 |
80 | toxin metabolic process (GO:0009404) | 2.82080634 |
81 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 2.81470827 |
82 | negative regulation of platelet activation (GO:0010544) | 2.80042208 |
83 | negative regulation of blood vessel morphogenesis (GO:2000181) | 2.78417527 |
84 | coronary vasculature morphogenesis (GO:0060977) | 2.75865698 |
85 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 2.74747113 |
86 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.74743579 |
87 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.72161825 |
88 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.72161825 |
89 | negative regulation of endothelial cell apoptotic process (GO:2000352) | 2.68440701 |
90 | regulation of systemic arterial blood pressure (GO:0003073) | 2.68428864 |
91 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.67965520 |
92 | regulation of cholesterol storage (GO:0010885) | 2.67447937 |
93 | transcytosis (GO:0045056) | 2.65837973 |
94 | ovulation from ovarian follicle (GO:0001542) | 2.63995966 |
95 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.63753569 |
96 | peptide catabolic process (GO:0043171) | 2.63440640 |
97 | negative regulation of vasculature development (GO:1901343) | 2.63292257 |
98 | positive regulation of cell junction assembly (GO:1901890) | 2.62652297 |
99 | positive regulation of focal adhesion assembly (GO:0051894) | 2.62652297 |
100 | heart trabecula formation (GO:0060347) | 2.62013937 |
101 | nephron epithelium development (GO:0072009) | 2.59780560 |
102 | embryonic heart tube development (GO:0035050) | 2.59401509 |
103 | * negative regulation of epithelial cell migration (GO:0010633) | 2.58934746 |
104 | embryonic foregut morphogenesis (GO:0048617) | 2.57507884 |
105 | positive regulation of epithelial cell migration (GO:0010634) | 2.57364439 |
106 | membrane raft organization (GO:0031579) | 2.56095643 |
107 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.56067696 |
108 | positive regulation of odontogenesis (GO:0042482) | 2.55852029 |
109 | response to laminar fluid shear stress (GO:0034616) | 2.55668085 |
110 | negative regulation of anoikis (GO:2000811) | 2.55343345 |
111 | regulation of establishment or maintenance of cell polarity (GO:0032878) | 2.54685457 |
112 | glomerular visceral epithelial cell development (GO:0072015) | 2.53259913 |
113 | regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947) | 2.53248563 |
114 | positive regulation of adherens junction organization (GO:1903393) | 2.52078097 |
115 | positive regulation of pseudopodium assembly (GO:0031274) | 2.51081875 |
116 | regulation of cell migration involved in sprouting angiogenesis (GO:0090049) | 2.50627881 |
117 | glomerular epithelial cell development (GO:0072310) | 2.49725508 |
118 | barbed-end actin filament capping (GO:0051016) | 2.49479468 |
119 | negative regulation of mast cell activation (GO:0033004) | 2.49336663 |
120 | regulation of macrophage chemotaxis (GO:0010758) | 2.48379572 |
121 | substrate adhesion-dependent cell spreading (GO:0034446) | 2.48214136 |
122 | regulation of glomerular filtration (GO:0003093) | 2.48070597 |
123 | semaphorin-plexin signaling pathway (GO:0071526) | 2.47804547 |
124 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.47713431 |
125 | arginine catabolic process (GO:0006527) | 2.46989340 |
126 | positive regulation of lipid kinase activity (GO:0090218) | 2.46816065 |
127 | endothelial cell migration (GO:0043542) | 2.46659880 |
128 | glomerular basement membrane development (GO:0032836) | 2.46375910 |
129 | hormone catabolic process (GO:0042447) | 2.45974956 |
130 | negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948) | 2.45624146 |
131 | * regulation of epithelial cell migration (GO:0010632) | 2.44985412 |
132 | negative regulation of fatty acid transport (GO:2000192) | 2.42603895 |
133 | ganglion development (GO:0061548) | 2.41985671 |
134 | regulation of pseudopodium assembly (GO:0031272) | 2.41845549 |
135 | establishment of apical/basal cell polarity (GO:0035089) | 2.40487513 |
136 | negative regulation of Rho protein signal transduction (GO:0035024) | 2.40051162 |
137 | growth hormone receptor signaling pathway (GO:0060396) | 2.39749507 |
138 | regulation of vascular permeability (GO:0043114) | 2.39719948 |
139 | negative regulation of chondrocyte differentiation (GO:0032331) | 2.39326744 |
140 | phagocytosis, recognition (GO:0006910) | 2.39138293 |
141 | cartilage development involved in endochondral bone morphogenesis (GO:0060351) | 2.38328436 |
142 | protein kinase C signaling (GO:0070528) | 2.38114252 |
143 | negative regulation of protein autophosphorylation (GO:0031953) | 2.38100000 |
144 | endocardial cushion development (GO:0003197) | 2.37015601 |
145 | chondrocyte proliferation (GO:0035988) | 2.36290047 |
146 | trabecula morphogenesis (GO:0061383) | 2.36260698 |
147 | regulation of macrophage cytokine production (GO:0010935) | 2.36168481 |
148 | regulation of endothelial cell apoptotic process (GO:2000351) | 2.35918156 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.76746575 |
2 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.81019466 |
3 | GATA1_22025678_ChIP-Seq_K562_Human | 3.65353212 |
4 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.27745852 |
5 | CLOCK_20551151_ChIP-Seq_293T_Human | 3.22625850 |
6 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.97990065 |
7 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.97036433 |
8 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.56853367 |
9 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.43969577 |
10 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.25474665 |
11 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.25029361 |
12 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.13187568 |
13 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.11349442 |
14 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.07995617 |
15 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.06036685 |
16 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.05754936 |
17 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.84302904 |
18 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.81526936 |
19 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.79547190 |
20 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.77673729 |
21 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.71625034 |
22 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.68511574 |
23 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.67169178 |
24 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.66958874 |
25 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.61334892 |
26 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.59062400 |
27 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.59062400 |
28 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.58362332 |
29 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.57735221 |
30 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.55927766 |
31 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.53889582 |
32 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.52107989 |
33 | CJUN_26792858_Chip-Seq_BT549_Human | 1.52036447 |
34 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.49716605 |
35 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.48928720 |
36 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.43169178 |
37 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.43169178 |
38 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.43046914 |
39 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.40987513 |
40 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.39505212 |
41 | * GATA1_19941826_ChIP-Seq_K562_Human | 1.38984599 |
42 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.37616174 |
43 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.36965238 |
44 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.36152808 |
45 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.35856750 |
46 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.35771404 |
47 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.35051841 |
48 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.34878014 |
49 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.34322852 |
50 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.33084959 |
51 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.31853191 |
52 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.31059404 |
53 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.29034144 |
54 | SPI1_23127762_ChIP-Seq_K562_Human | 1.28601506 |
55 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.27794971 |
56 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.27350482 |
57 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.27033617 |
58 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.26866540 |
59 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.26742475 |
60 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.22375078 |
61 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.21491989 |
62 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.21267994 |
63 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.19888940 |
64 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.18386297 |
65 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.17999005 |
66 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.17582999 |
67 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.16938936 |
68 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.16901090 |
69 | KDM2B_26808549_Chip-Seq_K562_Human | 1.16805132 |
70 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.16511800 |
71 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.15241003 |
72 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.14330593 |
73 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.14330593 |
74 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.13870528 |
75 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.13075748 |
76 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.13038454 |
77 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.12861523 |
78 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.12583457 |
79 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.12075728 |
80 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.11372555 |
81 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.09023663 |
82 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.07598266 |
83 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.07097856 |
84 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.06809015 |
85 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.05978795 |
86 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.05471416 |
87 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.03939717 |
88 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.03912589 |
89 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.03070464 |
90 | * SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.02963479 |
91 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.02933063 |
92 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.02734262 |
93 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 1.00151746 |
94 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.99088906 |
95 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.98726656 |
96 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.98171511 |
97 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.97652724 |
98 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.97617097 |
99 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.96383409 |
100 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.95769301 |
101 | MAF_26560356_Chip-Seq_TH1_Human | 0.95422220 |
102 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.94683515 |
103 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.93224594 |
104 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.93173304 |
105 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.93042559 |
106 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.92616816 |
107 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.92109066 |
108 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.91428358 |
109 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.90965117 |
110 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.90662281 |
111 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.89934866 |
112 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.89580808 |
113 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.88946884 |
114 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.88607338 |
115 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.88591217 |
116 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.88561617 |
117 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.88084395 |
118 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.87042347 |
119 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.86935417 |
120 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.86888480 |
121 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.86888480 |
122 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.86437226 |
123 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.85853719 |
124 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.85288900 |
125 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.85005240 |
126 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.84644030 |
127 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.84553308 |
128 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.84447407 |
129 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.83675866 |
130 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.82897149 |
131 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.81625702 |
132 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.81103385 |
133 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.80119275 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0010368_abnormal_lymphatic_system | 6.24841116 |
2 | MP0005167_abnormal_blood-brain_barrier | 5.14664498 |
3 | MP0001879_abnormal_lymphatic_vessel | 5.01860296 |
4 | MP0001958_emphysema | 4.01166666 |
5 | MP0004272_abnormal_basement_membrane | 3.59896912 |
6 | MP0003724_increased_susceptibility_to | 3.53594355 |
7 | MP0004782_abnormal_surfactant_physiolog | 3.02899295 |
8 | MP0008438_abnormal_cutaneous_collagen | 2.94243542 |
9 | MP0003828_pulmonary_edema | 2.54538245 |
10 | MP0003705_abnormal_hypodermis_morpholog | 2.47650113 |
11 | MP0003191_abnormal_cellular_cholesterol | 2.42025293 |
12 | MP0003566_abnormal_cell_adhesion | 2.32523497 |
13 | MP0003303_peritoneal_inflammation | 2.24739189 |
14 | MP0004084_abnormal_cardiac_muscle | 2.21430059 |
15 | MP0000343_altered_response_to | 2.19152644 |
16 | MP0003279_aneurysm | 2.08978285 |
17 | MP0005275_abnormal_skin_tensile | 2.04782125 |
18 | MP0006054_spinal_hemorrhage | 1.86940490 |
19 | MP0005409_darkened_coat_color | 1.85116515 |
20 | MP0006138_congestive_heart_failure | 1.84633755 |
21 | * MP0000767_abnormal_smooth_muscle | 1.82875767 |
22 | MP0002295_abnormal_pulmonary_circulatio | 1.76769807 |
23 | MP0000249_abnormal_blood_vessel | 1.75940472 |
24 | MP0005164_abnormal_response_to | 1.66712059 |
25 | MP0004510_myositis | 1.64834884 |
26 | MP0002933_joint_inflammation | 1.62924136 |
27 | MP0003300_gastrointestinal_ulcer | 1.61692839 |
28 | MP0009278_abnormal_bone_marrow | 1.56650477 |
29 | MP0004883_abnormal_blood_vessel | 1.54248553 |
30 | MP0005165_increased_susceptibility_to | 1.53408166 |
31 | MP0005388_respiratory_system_phenotype | 1.50719641 |
32 | MP0002133_abnormal_respiratory_system | 1.50719641 |
33 | MP0003091_abnormal_cell_migration | 1.49748909 |
34 | MP0001544_abnormal_cardiovascular_syste | 1.45325183 |
35 | MP0005385_cardiovascular_system_phenoty | 1.45325183 |
36 | * MP0000465_gastrointestinal_hemorrhage | 1.43323546 |
37 | MP0003075_altered_response_to | 1.38608200 |
38 | MP0002877_abnormal_melanocyte_morpholog | 1.32885559 |
39 | MP0002332_abnormal_exercise_endurance | 1.31938613 |
40 | MP0004036_abnormal_muscle_relaxation | 1.30613295 |
41 | MP0010030_abnormal_orbit_morphology | 1.27121619 |
42 | MP0005023_abnormal_wound_healing | 1.22371361 |
43 | * MP0005595_abnormal_vascular_smooth | 1.22144519 |
44 | MP0003950_abnormal_plasma_membrane | 1.20088843 |
45 | * MP0002128_abnormal_blood_circulation | 1.16116803 |
46 | MP0009764_decreased_sensitivity_to | 1.13626448 |
47 | MP0000013_abnormal_adipose_tissue | 1.12516428 |
48 | * MP0002925_abnormal_cardiovascular_devel | 1.12296325 |
49 | MP0001533_abnormal_skeleton_physiology | 1.11224810 |
50 | MP0003045_fibrosis | 1.10783796 |
51 | * MP0001614_abnormal_blood_vessel | 1.08779030 |
52 | MP0008775_abnormal_heart_ventricle | 1.08728793 |
53 | MP0009840_abnormal_foam_cell | 1.06074967 |
54 | MP0000751_myopathy | 1.06066809 |
55 | MP0004145_abnormal_muscle_electrophysio | 1.05544414 |
56 | MP0003868_abnormal_feces_composition | 1.05039034 |
57 | MP0001851_eye_inflammation | 1.04982279 |
58 | MP0001545_abnormal_hematopoietic_system | 1.04121778 |
59 | MP0005397_hematopoietic_system_phenotyp | 1.04121778 |
60 | MP0002896_abnormal_bone_mineralization | 1.03952922 |
61 | MP0009785_altered_susceptibility_to | 1.03351835 |
62 | MP0003448_altered_tumor_morphology | 1.02874555 |
63 | MP0005670_abnormal_white_adipose | 1.02600130 |
64 | MP0008995_early_reproductive_senescence | 1.01879256 |
65 | MP0004484_altered_response_of | 1.00769451 |
66 | MP0005257_abnormal_intraocular_pressure | 0.99215408 |
67 | MP0002972_abnormal_cardiac_muscle | 0.98887374 |
68 | MP0001849_ear_inflammation | 0.97362232 |
69 | MP0005058_abnormal_lysosome_morphology | 0.96432599 |
70 | MP0010630_abnormal_cardiac_muscle | 0.94857447 |
71 | MP0005166_decreased_susceptibility_to | 0.94548822 |
72 | MP0002132_abnormal_respiratory_system | 0.93976309 |
73 | MP0005360_urolithiasis | 0.93916728 |
74 | MP0004130_abnormal_muscle_cell | 0.93221821 |
75 | MP0001915_intracranial_hemorrhage | 0.93123326 |
76 | * MP0001175_abnormal_lung_morphology | 0.90072509 |
77 | MP0005503_abnormal_tendon_morphology | 0.89642820 |
78 | MP0005330_cardiomyopathy | 0.88008254 |
79 | MP0000003_abnormal_adipose_tissue | 0.87519792 |
80 | MP0005623_abnormal_meninges_morphology | 0.87289302 |
81 | MP0002108_abnormal_muscle_morphology | 0.86918685 |
82 | MP0008004_abnormal_stomach_pH | 0.83293444 |
83 | MP0002127_abnormal_cardiovascular_syste | 0.82968627 |
84 | MP0004085_abnormal_heartbeat | 0.82242645 |
85 | MP0002166_altered_tumor_susceptibility | 0.81452527 |
86 | MP0003436_decreased_susceptibility_to | 0.80950715 |
87 | MP0008875_abnormal_xenobiotic_pharmacok | 0.80839834 |
88 | MP0002419_abnormal_innate_immunity | 0.79233933 |
89 | MP0002998_abnormal_bone_remodeling | 0.79162358 |
90 | MP0004858_abnormal_nervous_system | 0.78445650 |
91 | MP0004215_abnormal_myocardial_fiber | 0.78135873 |
92 | MP0000230_abnormal_systemic_arterial | 0.76723641 |
93 | MP0005508_abnormal_skeleton_morphology | 0.75910458 |
94 | MP0000750_abnormal_muscle_regeneration | 0.75270610 |
95 | MP0001790_abnormal_immune_system | 0.74483237 |
96 | MP0005387_immune_system_phenotype | 0.74483237 |
97 | MP0009780_abnormal_chondrocyte_physiolo | 0.73589955 |
98 | MP0004087_abnormal_muscle_fiber | 0.71368365 |
99 | MP0005464_abnormal_platelet_physiology | 0.70996675 |
100 | * MP0000266_abnormal_heart_morphology | 0.70176651 |
101 | MP0005025_abnormal_response_to | 0.69140142 |
102 | MP0004233_abnormal_muscle_weight | 0.69013233 |
103 | MP0003283_abnormal_digestive_organ | 0.67878104 |
104 | MP0005620_abnormal_muscle_contractility | 0.66644929 |
105 | MP0002837_dystrophic_cardiac_calcinosis | 0.66223284 |
106 | MP0001663_abnormal_digestive_system | 0.66198147 |
107 | MP0001835_abnormal_antigen_presentation | 0.65484848 |
108 | MP0001756_abnormal_urination | 0.65445836 |
109 | MP0000749_muscle_degeneration | 0.64587497 |
110 | MP0010234_abnormal_vibrissa_follicle | 0.64516557 |
111 | MP0002277_abnormal_respiratory_mucosa | 0.64404865 |
112 | MP0002168_other_aberrant_phenotype | 0.64390499 |
113 | MP0003941_abnormal_skin_development | 0.64086720 |
114 | MP0005375_adipose_tissue_phenotype | 0.63079891 |
115 | MP0005084_abnormal_gallbladder_morpholo | 0.62646728 |
116 | MP0009384_cardiac_valve_regurgitation | 0.62175756 |
117 | MP0001784_abnormal_fluid_regulation | 0.61668352 |
118 | MP0002405_respiratory_system_inflammati | 0.59910579 |
119 | MP0010155_abnormal_intestine_physiology | 0.59478761 |
120 | MP0000685_abnormal_immune_system | 0.59379058 |
121 | MP0001542_abnormal_bone_strength | 0.59275614 |
122 | MP0000467_abnormal_esophagus_morphology | 0.58847733 |
123 | MP0005390_skeleton_phenotype | 0.58106094 |
124 | MP0002136_abnormal_kidney_physiology | 0.57933960 |
125 | MP0001177_atelectasis | 0.57437393 |
126 | MP0000759_abnormal_skeletal_muscle | 0.56193459 |
127 | MP0010352_gastrointestinal_tract_polyps | 0.53919612 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Interstitial pulmonary disease (HP:0006530) | 5.62102720 |
2 | * Polycythemia (HP:0001901) | 4.95472801 |
3 | Cerebral aneurysm (HP:0004944) | 4.59122766 |
4 | Hyperactive renin-angiotensin system (HP:0000841) | 4.19952964 |
5 | Broad metatarsal (HP:0001783) | 3.86299816 |
6 | * Hematochezia (HP:0002573) | 3.64942938 |
7 | Eczematoid dermatitis (HP:0000976) | 3.63620811 |
8 | * Spontaneous hematomas (HP:0007420) | 3.60878684 |
9 | Aortic aneurysm (HP:0004942) | 3.48692960 |
10 | Pulmonary artery stenosis (HP:0004415) | 3.20459160 |
11 | Cervical subluxation (HP:0003308) | 3.09013423 |
12 | Deep venous thrombosis (HP:0002625) | 3.06004275 |
13 | * Abnormality of the nasal mucosa (HP:0000433) | 3.04592840 |
14 | * Esophageal varix (HP:0002040) | 2.99751520 |
15 | Skull defect (HP:0001362) | 2.98383239 |
16 | Increased connective tissue (HP:0009025) | 2.97513422 |
17 | Aortic dissection (HP:0002647) | 2.95784291 |
18 | Vascular tortuosity (HP:0004948) | 2.83279343 |
19 | Long toe (HP:0010511) | 2.82641072 |
20 | Aneurysm (HP:0002617) | 2.81990675 |
21 | Growth hormone excess (HP:0000845) | 2.81470566 |
22 | Premature rupture of membranes (HP:0001788) | 2.79896340 |
23 | Overgrowth (HP:0001548) | 2.78172593 |
24 | Protrusio acetabuli (HP:0003179) | 2.77664745 |
25 | Chronic bronchitis (HP:0004469) | 2.77513499 |
26 | Camptodactyly of toe (HP:0001836) | 2.77228721 |
27 | Hip contracture (HP:0003273) | 2.76110710 |
28 | Type 1 muscle fiber predominance (HP:0003803) | 2.74613973 |
29 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.72093430 |
30 | Distal lower limb muscle weakness (HP:0009053) | 2.70488727 |
31 | Increased variability in muscle fiber diameter (HP:0003557) | 2.69932515 |
32 | Arterial tortuosity (HP:0005116) | 2.64133339 |
33 | Facial shape deformation (HP:0011334) | 2.63323975 |
34 | Potter facies (HP:0002009) | 2.63323975 |
35 | Wormian bones (HP:0002645) | 2.62484302 |
36 | Right ventricular cardiomyopathy (HP:0011663) | 2.62320426 |
37 | Nonimmune hydrops fetalis (HP:0001790) | 2.60545439 |
38 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.60076608 |
39 | Osteolytic defects of the hand bones (HP:0009699) | 2.60076608 |
40 | Lymphangioma (HP:0100764) | 2.58797422 |
41 | Hyperkalemia (HP:0002153) | 2.57879144 |
42 | Tetraparesis (HP:0002273) | 2.54601424 |
43 | Spinal rigidity (HP:0003306) | 2.53891554 |
44 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.50866475 |
45 | Mitral valve prolapse (HP:0001634) | 2.49322787 |
46 | Shallow orbits (HP:0000586) | 2.46798484 |
47 | Muscle fiber splitting (HP:0003555) | 2.46203321 |
48 | Myotonia (HP:0002486) | 2.45708685 |
49 | Ankle contracture (HP:0006466) | 2.45057306 |
50 | * Pulmonary hypertension (HP:0002092) | 2.44868726 |
51 | Amyloidosis (HP:0011034) | 2.43854116 |
52 | Blue sclerae (HP:0000592) | 2.42037655 |
53 | Absent hand (HP:0004050) | 2.41187953 |
54 | Systemic lupus erythematosus (HP:0002725) | 2.40427945 |
55 | Abnormal vertebral ossification (HP:0100569) | 2.38395468 |
56 | Hydroureter (HP:0000072) | 2.36497572 |
57 | Complement deficiency (HP:0004431) | 2.32433378 |
58 | Ventricular tachycardia (HP:0004756) | 2.31888322 |
59 | Renal salt wasting (HP:0000127) | 2.30071433 |
60 | Disproportionate tall stature (HP:0001519) | 2.30061210 |
61 | Limited hip movement (HP:0008800) | 2.29721732 |
62 | Difficulty climbing stairs (HP:0003551) | 2.29300111 |
63 | Wrist flexion contracture (HP:0001239) | 2.28745649 |
64 | Nephritis (HP:0000123) | 2.27767581 |
65 | Single umbilical artery (HP:0001195) | 2.26231035 |
66 | Abnormality of the fetal cardiovascular system (HP:0010948) | 2.26231035 |
67 | Abnormal umbilical cord blood vessels (HP:0011403) | 2.26231035 |
68 | Joint stiffness (HP:0001387) | 2.23216064 |
69 | Distal lower limb amyotrophy (HP:0008944) | 2.23207333 |
70 | Joint contractures involving the joints of the feet (HP:0100492) | 2.22677642 |
71 | Flexion contracture of toe (HP:0005830) | 2.22677642 |
72 | Bladder diverticulum (HP:0000015) | 2.22202687 |
73 | Hyporeflexia of lower limbs (HP:0002600) | 2.20019415 |
74 | Annular pancreas (HP:0001734) | 2.19383911 |
75 | Sudden death (HP:0001699) | 2.15278068 |
76 | Flat acetabular roof (HP:0003180) | 2.14569295 |
77 | Porencephaly (HP:0002132) | 2.12050917 |
78 | Aortic valve stenosis (HP:0001650) | 2.11432643 |
79 | Ectopia lentis (HP:0001083) | 2.09734389 |
80 | Soft skin (HP:0000977) | 2.06837820 |
81 | Striae distensae (HP:0001065) | 2.06754577 |
82 | Coxa vara (HP:0002812) | 2.05465161 |
83 | Hemorrhage of the eye (HP:0011885) | 2.04922932 |
84 | Vertebral clefting (HP:0008428) | 2.04421045 |
85 | Vertebral compression fractures (HP:0002953) | 2.03806039 |
86 | Rectal prolapse (HP:0002035) | 2.03407141 |
87 | Atrophic scars (HP:0001075) | 2.03337515 |
88 | Broad face (HP:0000283) | 2.03217627 |
89 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.00225550 |
90 | * Visceral angiomatosis (HP:0100761) | 2.00140446 |
91 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.99892776 |
92 | Mucopolysacchariduria (HP:0008155) | 1.99892776 |
93 | Abnormality of the acetabulum (HP:0003170) | 1.98936370 |
94 | Venous abnormality (HP:0002624) | 1.98860389 |
95 | Joint laxity (HP:0001388) | 1.97705098 |
96 | Hypoplasia of the iris (HP:0007676) | 1.97440124 |
97 | Mesangial abnormality (HP:0001966) | 1.96906214 |
98 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.95993642 |
99 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.95993642 |
100 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.95993642 |
101 | Tubulointerstitial fibrosis (HP:0005576) | 1.93271329 |
102 | Menorrhagia (HP:0000132) | 1.92993076 |
103 | Round ear (HP:0100830) | 1.92459126 |
104 | Mitral stenosis (HP:0001718) | 1.92382839 |
105 | Adactyly (HP:0009776) | 1.92268681 |
106 | Dysostosis multiplex (HP:0000943) | 1.92050238 |
107 | Tachypnea (HP:0002789) | 1.91684704 |
108 | Neonatal death (HP:0003811) | 1.91439300 |
109 | Venous insufficiency (HP:0005293) | 1.90566740 |
110 | Chondrocalcinosis (HP:0000934) | 1.89248545 |
111 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.89196532 |
112 | Difficulty running (HP:0009046) | 1.88981954 |
113 | Dilatation of the ascending aorta (HP:0005111) | 1.88629000 |
114 | Increased cerebral lipofuscin (HP:0011813) | 1.88468426 |
115 | Hyperaldosteronism (HP:0000859) | 1.87728208 |
116 | * Hemangiomatosis (HP:0007461) | 1.86661443 |
117 | Abnormality of glycolipid metabolism (HP:0010969) | 1.85623556 |
118 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.85623556 |
119 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.85623556 |
120 | Asymmetric septal hypertrophy (HP:0001670) | 1.85359405 |
121 | Pigmentary retinal degeneration (HP:0001146) | 1.84872476 |
122 | Subacute progressive viral hepatitis (HP:0006572) | 1.84238359 |
123 | Rapidly progressive (HP:0003678) | 1.84143778 |
124 | Ulnar bowing (HP:0003031) | 1.83503943 |
125 | Myocardial infarction (HP:0001658) | 1.83254333 |
126 | Short 4th metacarpal (HP:0010044) | 1.82990148 |
127 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 1.82990148 |
128 | Acanthosis nigricans (HP:0000956) | 1.82432134 |
129 | * Portal hypertension (HP:0001409) | 1.82253248 |
130 | Neonatal short-limb short stature (HP:0008921) | 1.82143647 |
131 | Recurrent abscess formation (HP:0002722) | 1.81517761 |
132 | Peritonitis (HP:0002586) | 1.80990006 |
133 | Decreased circulating renin level (HP:0003351) | 1.80920928 |
134 | Facial diplegia (HP:0001349) | 1.79987394 |
135 | Hypotension (HP:0002615) | 1.79854088 |
136 | Bronchitis (HP:0012387) | 1.78465767 |
137 | Asymmetry of the thorax (HP:0001555) | 1.77979204 |
138 | Abnormality of complement system (HP:0005339) | 1.77760801 |
139 | Cardiovascular calcification (HP:0011915) | 1.77433370 |
140 | J-shaped sella turcica (HP:0002680) | 1.77341111 |
141 | Follicular hyperkeratosis (HP:0007502) | 1.76013073 |
142 | Fragile skin (HP:0001030) | 1.75818263 |
143 | Abnormality of renin-angiotensin system (HP:0000847) | 1.74931091 |
144 | Ovoid vertebral bodies (HP:0003300) | 1.74785081 |
145 | Autoimmune thrombocytopenia (HP:0001973) | 1.74457614 |
146 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.74250064 |
147 | Bone cyst (HP:0012062) | 1.73749090 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TIE1 | 9.48580888 |
2 | TGFBR2 | 4.71969050 |
3 | KDR | 4.32516814 |
4 | RIPK1 | 2.79206723 |
5 | ERN1 | 2.67972666 |
6 | TRIB3 | 2.41442246 |
7 | EPHB1 | 2.06922597 |
8 | TGFBR1 | 2.01907387 |
9 | EPHB2 | 1.98546923 |
10 | TTN | 1.95259695 |
11 | GRK1 | 1.86786931 |
12 | CSK | 1.78396067 |
13 | MYLK | 1.77417051 |
14 | FGFR4 | 1.69247161 |
15 | PTK6 | 1.58763850 |
16 | LRRK2 | 1.55373748 |
17 | PTK2B | 1.54834688 |
18 | PDGFRA | 1.53755997 |
19 | PAK4 | 1.49262844 |
20 | FER | 1.48428968 |
21 | PKN2 | 1.34801105 |
22 | STK10 | 1.31993273 |
23 | NTRK1 | 1.30300038 |
24 | MAP2K3 | 1.24631260 |
25 | DMPK | 1.18876284 |
26 | TBK1 | 1.11525569 |
27 | EPHA3 | 1.03613193 |
28 | MAP3K3 | 1.02007552 |
29 | TYK2 | 0.99696647 |
30 | FGFR3 | 0.97158963 |
31 | EPHA2 | 0.94993018 |
32 | PRKG2 | 0.93504805 |
33 | PTK2 | 0.92154578 |
34 | ZAP70 | 0.91991983 |
35 | INSRR | 0.88940031 |
36 | PRKD1 | 0.87823818 |
37 | FGFR2 | 0.85888057 |
38 | JAK1 | 0.84483447 |
39 | MAPKAPK3 | 0.84391099 |
40 | TEC | 0.84217589 |
41 | PRKCH | 0.83217408 |
42 | PDGFRB | 0.82136293 |
43 | TESK1 | 0.81483585 |
44 | MAP4K1 | 0.80112144 |
45 | CDC42BPA | 0.78095830 |
46 | BLK | 0.77465502 |
47 | RPS6KA2 | 0.77134872 |
48 | DAPK2 | 0.74993308 |
49 | KIT | 0.73328446 |
50 | FGR | 0.73224676 |
51 | MAPK7 | 0.66853987 |
52 | LATS2 | 0.65930553 |
53 | PIK3CA | 0.65908854 |
54 | EEF2K | 0.65721531 |
55 | LMTK2 | 0.63920300 |
56 | MAP3K1 | 0.63918420 |
57 | FES | 0.63415557 |
58 | ABL2 | 0.62049499 |
59 | PDPK1 | 0.61397474 |
60 | ILK | 0.61161038 |
61 | IKBKE | 0.60970382 |
62 | MAP3K6 | 0.59870145 |
63 | DDR2 | 0.59862873 |
64 | EGFR | 0.58633746 |
65 | ITK | 0.57864220 |
66 | JAK3 | 0.57531015 |
67 | CAMK1D | 0.56751643 |
68 | MARK3 | 0.55961506 |
69 | JAK2 | 0.55112734 |
70 | NEK9 | 0.53445789 |
71 | MARK2 | 0.51806091 |
72 | PDK2 | 0.51223101 |
73 | RET | 0.50675074 |
74 | IRAK3 | 0.50615437 |
75 | MAPK12 | 0.50032390 |
76 | ACVR1B | 0.49106261 |
77 | GSK3A | 0.48775454 |
78 | HCK | 0.48718157 |
79 | FLT3 | 0.47076218 |
80 | MET | 0.46180172 |
81 | KSR2 | 0.45768769 |
82 | PRKD3 | 0.45132841 |
83 | MAP3K11 | 0.44961199 |
84 | GRK7 | 0.44893837 |
85 | SRC | 0.44745728 |
86 | MATK | 0.44186326 |
87 | MAP3K14 | 0.42305285 |
88 | LIMK1 | 0.42214558 |
89 | OBSCN | 0.41137144 |
90 | BMX | 0.40748784 |
91 | MST1R | 0.40556317 |
92 | PIK3CG | 0.40339696 |
93 | NLK | 0.39669704 |
94 | MAP3K2 | 0.38491958 |
95 | ROCK1 | 0.36882971 |
96 | IGF1R | 0.36821671 |
97 | DAPK3 | 0.36096000 |
98 | MAP3K7 | 0.34809031 |
99 | PAK2 | 0.34175029 |
100 | MAP2K2 | 0.34025439 |
101 | CAMK1G | 0.33255152 |
102 | FYN | 0.32711916 |
103 | GRK5 | 0.32419143 |
104 | MAPK15 | 0.32064593 |
105 | IRAK1 | 0.31707607 |
106 | INSR | 0.30861390 |
107 | STK24 | 0.30771456 |
108 | TYRO3 | 0.30505978 |
109 | TRPM7 | 0.29462512 |
110 | PRKD2 | 0.29268531 |
111 | MOS | 0.28839405 |
112 | ABL1 | 0.28276629 |
113 | ERBB4 | 0.27565762 |
114 | RPS6KC1 | 0.27314298 |
115 | RPS6KL1 | 0.27314298 |
116 | PHKG1 | 0.26980527 |
117 | PHKG2 | 0.26980527 |
118 | MAP2K1 | 0.25507100 |
119 | RIPK4 | 0.25316272 |
120 | PRKAA2 | 0.24870683 |
121 | MAPK4 | 0.24112042 |
122 | FGFR1 | 0.24027436 |
123 | ROCK2 | 0.23937457 |
124 | STK39 | 0.23819205 |
125 | LATS1 | 0.23446608 |
126 | CAMK4 | 0.22845959 |
127 | ADRBK1 | 0.22762605 |
128 | RPS6KA6 | 0.22688430 |
129 | PRPF4B | 0.21351442 |
130 | SIK1 | 0.21112791 |
131 | AKT3 | 0.20215419 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ECM-receptor interaction_Homo sapiens_hsa04512 | 2.46930846 |
2 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 2.31744684 |
3 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 2.23132211 |
4 | Focal adhesion_Homo sapiens_hsa04510 | 2.22372073 |
5 | Adherens junction_Homo sapiens_hsa04520 | 1.87807502 |
6 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.87349551 |
7 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.77638856 |
8 | Malaria_Homo sapiens_hsa05144 | 1.74044704 |
9 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.69537474 |
10 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.64416095 |
11 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.62345635 |
12 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.62095095 |
13 | Pertussis_Homo sapiens_hsa05133 | 1.56826526 |
14 | Amoebiasis_Homo sapiens_hsa05146 | 1.56460743 |
15 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.54005560 |
16 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.53309764 |
17 | Platelet activation_Homo sapiens_hsa04611 | 1.48960295 |
18 | Leishmaniasis_Homo sapiens_hsa05140 | 1.46498231 |
19 | Viral myocarditis_Homo sapiens_hsa05416 | 1.44072426 |
20 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.43330353 |
21 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 1.39768390 |
22 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.37470062 |
23 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.31722919 |
24 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.31383020 |
25 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.30545027 |
26 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.30147281 |
27 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.29343453 |
28 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.26599278 |
29 | Lysosome_Homo sapiens_hsa04142 | 1.25821165 |
30 | Salmonella infection_Homo sapiens_hsa05132 | 1.22254121 |
31 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.21797916 |
32 | Renin secretion_Homo sapiens_hsa04924 | 1.20555298 |
33 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.20508069 |
34 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.19615849 |
35 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.16671168 |
36 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.14674255 |
37 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.14563964 |
38 | Tight junction_Homo sapiens_hsa04530 | 1.10038729 |
39 | Phagosome_Homo sapiens_hsa04145 | 1.09630656 |
40 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.08208339 |
41 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.08040123 |
42 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.06739141 |
43 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.06371513 |
44 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.04555215 |
45 | Endocytosis_Homo sapiens_hsa04144 | 1.04340139 |
46 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.04189038 |
47 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.99466857 |
48 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.98740316 |
49 | Shigellosis_Homo sapiens_hsa05131 | 0.98188708 |
50 | Insulin resistance_Homo sapiens_hsa04931 | 0.95457617 |
51 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.94648445 |
52 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.93752766 |
53 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.93106105 |
54 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.92931179 |
55 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.91377202 |
56 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.87147770 |
57 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.84596652 |
58 | Tuberculosis_Homo sapiens_hsa05152 | 0.84350290 |
59 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.84114639 |
60 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.83418311 |
61 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.82974200 |
62 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.82038970 |
63 | Bladder cancer_Homo sapiens_hsa05219 | 0.79445683 |
64 | Axon guidance_Homo sapiens_hsa04360 | 0.79272526 |
65 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.79075194 |
66 | Hepatitis C_Homo sapiens_hsa05160 | 0.78991663 |
67 | Pathways in cancer_Homo sapiens_hsa05200 | 0.76787042 |
68 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.76534478 |
69 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.76214257 |
70 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.73869554 |
71 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.73028858 |
72 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.72387155 |
73 | Mineral absorption_Homo sapiens_hsa04978 | 0.70235678 |
74 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.69914498 |
75 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.69596358 |
76 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.69423419 |
77 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.69301126 |
78 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.69285402 |
79 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.68932130 |
80 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.68826687 |
81 | Histidine metabolism_Homo sapiens_hsa00340 | 0.68776496 |
82 | Prion diseases_Homo sapiens_hsa05020 | 0.67802555 |
83 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.66963817 |
84 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.66650724 |
85 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.66633187 |
86 | Apoptosis_Homo sapiens_hsa04210 | 0.64267538 |
87 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.64115288 |
88 | Bile secretion_Homo sapiens_hsa04976 | 0.63558626 |
89 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.63274957 |
90 | Influenza A_Homo sapiens_hsa05164 | 0.63045974 |
91 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.62730261 |
92 | Gap junction_Homo sapiens_hsa04540 | 0.60727294 |
93 | Measles_Homo sapiens_hsa05162 | 0.58749227 |
94 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.58413463 |
95 | Legionellosis_Homo sapiens_hsa05134 | 0.58378468 |
96 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.58187976 |
97 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.58124106 |
98 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.57598551 |
99 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.53550530 |
100 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.53407606 |
101 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.51398053 |
102 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.50872392 |
103 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.50515523 |
104 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.50432925 |
105 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.50271773 |
106 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.49045036 |
107 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.48957609 |
108 | Other glycan degradation_Homo sapiens_hsa00511 | 0.48582919 |
109 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.47861296 |
110 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.46295175 |
111 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.46252788 |
112 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.46181004 |
113 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.46111938 |
114 | Salivary secretion_Homo sapiens_hsa04970 | 0.45929242 |
115 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.45532281 |
116 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.44649081 |
117 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.41547827 |
118 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.38891752 |
119 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.38653936 |
120 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.36591131 |
121 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.36299972 |
122 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.36168364 |
123 | Melanogenesis_Homo sapiens_hsa04916 | 0.35438766 |